What is he best known for?
The fields of study he is best known for:
Plasminogen activator, Molecular biology, Urokinase, Biochemistry and Urokinase receptor are his primary areas of study.
Peter A. Andreasen studies Plasminogen activator inhibitor-1 which is a part of Plasminogen activator.
His Molecular biology research is multidisciplinary, incorporating elements of Amino acid, Peptide sequence and Zymography.
The various areas that Peter A. Andreasen examines in his Urokinase study include Enzyme inhibitor, Enzyme and Mammary gland.
His work carried out in the field of Urokinase receptor brings together such families of science as Plasminogen activator inhibitor-2, Cell surface receptor, Tumor progression, Extracellular matrix and Receptor expression.
His Proteolysis research includes elements of Zymogen and Somatomedin B.
His most cited work include:
- Plasminogen activators, tissue degradation, and cancer. (2288 citations)
- THE UROKINASE-TYPE PLASMINOGEN ACTIVATOR SYSTEM IN CANCER METASTASIS: A REVIEW (1424 citations)
- The plasminogen activation system in tumor growth, invasion, and metastasis. (799 citations)
What are the main themes of his work throughout his whole career to date?
Peter A. Andreasen spends much of his time researching Plasminogen activator, Biochemistry, Molecular biology, Plasminogen activator inhibitor-1 and Serpin.
His Plasminogen activator research focuses on Urokinase receptor in particular.
His Urokinase receptor study incorporates themes from Cell surface receptor and Cell biology.
His research investigates the link between Molecular biology and topics such as Cell culture that cross with problems in Plasminogen Inactivators.
His research on Plasminogen activator inhibitor-1 also deals with topics like
- Pathology which connect with Oncology, Metastasis, Internal medicine and Breast cancer,
- Cancer cell that intertwine with fields like Stromal cell.
His studies in Urokinase integrate themes in fields like Cancer, Cancer research and Gel electrophoresis.
He most often published in these fields:
- Plasminogen activator (59.34%)
- Biochemistry (46.89%)
- Molecular biology (31.95%)
What were the highlights of his more recent work (between 2009-2020)?
- Biochemistry (46.89%)
- Plasminogen activator (59.34%)
- Serine protease (12.03%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Biochemistry, Plasminogen activator, Serine protease, Proteases and Protease.
His study in Biochemistry is interdisciplinary in nature, drawing from both Plasminogen activator inhibitor-1 and Aptamer.
Peter A. Andreasen studies Plasminogen activator, focusing on Urokinase receptor in particular.
His Proteases research is multidisciplinary, relying on both Serine, Zymogen, Hepatocyte Growth Factor Activator, Activator and Kringle domain.
Peter A. Andreasen usually deals with Protease and limits it to topics linked to Protein folding and Mutation, Proteolysis and Conserved sequence.
His biological study spans a wide range of topics, including Molecular biology, Stromal cell and Intravasation, Metastasis.
Between 2009 and 2020, his most popular works were:
- Structural Basis for Recognition of Urokinase-type Plasminogen Activator by Plasminogen Activator Inhibitor-1 (57 citations)
- RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1 (32 citations)
- Activation of Pro-uPA Is Critical for Initial Escape from the Primary Tumor and Hematogenous Dissemination of Human Carcinoma Cells (31 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Biochemistry, Plasminogen activator, Serpin, Plasminogen activator inhibitor-1 and Vitronectin.
He works mostly in the field of Biochemistry, limiting it down to concerns involving Aptamer and, occasionally, RNA and Systematic evolution of ligands by exponential enrichment.
His work is dedicated to discovering how Plasminogen activator, Urokinase are connected with Cell biology and other disciplines.
Peter A. Andreasen has included themes like Wild type, Fibrinolysis, Conformational change and Binding site in his Serpin study.
The Plasminogen activator inhibitor-1 study which covers Biophysics that intersects with Hydrogen–deuterium exchange.
His research in Urokinase receptor intersects with topics in Cancer cell, Metastasis and Plasmin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
